Zhengzhou Central Hospital Affiliated to Zhengzhou University | China
Dr. Shoukui Hu is a distinguished medical microbiologist and molecular biologist currently serving as the Director of the Clinical Laboratory and Blood Transfusion Department at Peking University Shougang Hospital. With over two decades of impactful work in pathogenic biology, Dr. Hu has been instrumental in advancing public health diagnostics and molecular epidemiology in China. His leadership and research contributions have strengthened clinical laboratory practices and disease surveillance.
Author Profile👤
ORCID
Scopus
Strengths for the Awards✨
Dr. Shoukui Hu brings over two decades of experience in pathogenic biology and molecular biology, having contributed significantly to public health and clinical research in China. He currently serves as the Director of the Clinical Laboratory and Blood Transfusion Department at Peking University Shougang Hospital, a role that highlights both his leadership capabilities and clinical expertise. His academic journey, culminating in a Ph.D. from the China CDC, laid a solid foundation for impactful research in infectious diseases, microbiology, and translational diagnostics.
A standout strength is his strong publication record, with at least nine peer-reviewed SCI-indexed articles published in the past five years alone—many as corresponding or first author. These papers cover emerging infectious pathogens such as Candida auris, Helicobacter pylori, Neisseria meningitidis, and Streptococcus pneumoniae, which are critical topics in global public health. His research has been published in high-impact Q1 and Q2 journals such as Gut Microbes, Helicobacter, BMC Genomics, and World Journal of Gastroenterology, demonstrating relevance, innovation, and scientific rigor.
Furthermore, Dr. Hu’s expertise in molecular diagnostics, particularly the development of biosensors and amplification techniques, shows clear translational value, directly impacting clinical diagnostics and public health surveillance systems. His dual expertise in research and hospital management positions him as a bridge between science and clinical application—an invaluable trait for advancing healthcare innovations.
🎓 Education
Dr. Hu began his academic journey with a BSc from Anhui Science and Technology University (1995–1999), followed by an MSc in Microbiology (2001–2004) jointly awarded by the National Institute for Communicable Disease Control and Prevention and Anhui Agricultural University. He then earned his Ph.D. in Pathogeny Biology (2009–2014) from the same institute under the China CDC, equipping him with a deep scientific foundation to drive impactful research.
🧪 Experience
Currently the Senior Technologist and Director at Peking University Shougang Hospital (since 2016), Dr. Hu has also held vital roles such as Postdoctoral Fellow in Molecular Epidemiology at the China CDC (2014–2016) and Associate Senior Technologist at Peking University International Hospital (2014). From 2004 to 2014, he served as Deputy Department Director of the Microbiology Lab at Anhui CDC, where he led several high-level surveillance and diagnostic programs across China.
Dr. Hu’s research passion lies at the intersection of pathogenic biology and molecular biology. He is particularly focused on Helicobacter pylori infections, gut microbiota, antimicrobial resistance, and the genomic characterization of emerging pathogens. His studies contribute valuable insight into immune mechanisms, pathogen identification, and microbiome-related diseases.
🏆 Awards
While specific awards are not listed in the provided CV, Dr. Hu’s consistent corresponding authorship and leadership in high-impact international publications indicate significant professional recognition. His role in directing laboratory operations at a top-tier hospital and publishing in top Q1 journals further reflects his prestige and contributions to global health science.
📚 Publications
Below are key publications from the past 5 years, with hyperlinks, journal names, years, and citation roles:
-
Isolation of Fluconazole-Resistant South Asian Clade Candida auris in Beijing, China, American Journal of Tropical Medicine and Hygiene, 2025 – Corresponding Author
-
Influence of Helicobacter pylori on composition and function of gastric microbiota in patients with chronic non-atrophic gastritis, Heliyon, 2024 – Corresponding Author
-
The role of toll-like receptors in immune tolerance induced by Helicobacter pylori infection, Helicobacter, 2023 – Corresponding Author
-
Comparative analysis of the gut microbiota of wild adult rats from nine district areas in Hainan, China, World Journal of Gastroenterology, 2023 – Corresponding Author
-
Ultra-efficient multiple cross displacement amplification-lateral flow biosensor for serogroup identification of prevalent Neisseria meningitidis, Analytical Biochemistry, 2022 – Corresponding Author
-
Simultaneous detection of Streptococcus pneumoniae… using multiple cross displacement amplification, FEMS Microbiology Letters, 2021 – Corresponding Author
-
Hemolysin BL from Bacillus toyonensis BV-17 induces antitumor activity both in vitro and in vivo, Gut Microbes, 2020 – Co-First Author
-
Genomic analysis of Helicobacter himalayensis sp. nov. isolated from Marmota himalayana, BMC Genomics, 2020 – First Author
-
Alteration of gut microbiota in type 2 diabetes complicated with cholelithiasis patients, Chinese Medical Journal, 2022 – Corresponding Author
✅ Conclusion
🎖️ Dr. Shoukui Hu is a pioneering clinical researcher and laboratory expert whose work spans epidemiological surveillance, diagnostic innovation, and microbiome science. With a sustained record of leadership, publication, and mentorship, he exemplifies the qualities of a Best Researcher Award nominee. His scholarly output and translational impact make him a key contributor to advancing infectious disease control and laboratory science in China and beyond.
